Cargando…
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
Autores principales: | Zeng, Cong, Evans, John P., Chakravarthy, Karthik, Qu, Panke, Reisinger, Sarah, Song, No-Joon, Rubinstein, Mark P., Shields, Peter G., Li, Zihai, Liu, Shan-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716174/ https://www.ncbi.nlm.nih.gov/pubmed/34986328 http://dx.doi.org/10.1016/j.ccell.2021.12.014 |
Ejemplares similares
-
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
por: Zuo, Fanglei, et al.
Publicado: (2022) -
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
por: Zeng, Cong, et al.
Publicado: (2021) -
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
por: Zeng, Cong, et al.
Publicado: (2021) -
Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022) -
Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)